Association between inhaled β-agonists and the risk of unstable angina and myocardial infarction

Chest

Volumn 121, Issue 3, 2002, Pages 846-851

  Au, David H ^a   Curtis, J Randall ^a   Every, Nathan R ^a   McDonell, Mary B ^a   Fihn, Stephan D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Angina pectoris; Asthma; Cardiovascular disease; COPD; Drug; Myocardial ischemia; Obstructive pulmonary disease; adrenoceptor; agonists

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DOSE RESPONSE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; UNSTABLE ANGINA PECTORIS;

EID: 0036210274     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.3.846     Document Type: Article

References (17)

1. A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results
2. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
3. Elevation of β-adrenergic receptor density in human lymphocytes after propranolol administration
4. The relative risk of incident coronary heart disease associated with recently stopping the use of β-blockers
5. 2-agonist bronchodilators
6. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma
7. The role of cardiac receptors in the hemodynamic response to a beta-2 agonist
8. Bronchodilators and acute cardiac death
9. The risk of myocardial infarction associated with inhaled β-adrenoceptor agonists
10. A general method of compliance assessment using centralized pharmacy records: Description and validation
11. The assessment of refill compliance using pharmacy records: Methods, validity, and applications
12. Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia
13. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma
14. Acute respiratory-tract infections and risk of first-time acute myocardial infarction
15. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD
16. Relationship between symptoms and health-related quality of life in chronic lung disease
17. Testing the measurement properties of the Spanish version of the SF-36 health survey among male patients with chronic obstructive pulmonary disease: Quality of life in COPD study group